Cancer is the leading cause of death in the Hispanic population in the U.S. Our study focuses on collecting information to build a cancer registry from a diverse Hispanic population to identify specific cultural and demographic details that will allow us to determine which attribute carries a higher risk of a poor outcome. We will also be utilizing a set of questionnaires and surveys that evaluate the health and functionality of older adults thoroughly and efficiently. These surveys provide a wealth of prognostic data and have been shown to detect deficits even in younger patients. Although the information we hope to collect is of considerable value, we must first examine whether our approach to consenting patients and having them complete these questionnaires is feasible. We anticipate that the findings from our study will provide valuable insights on Hispanic adults with cancer as a unique and growing patient population in the U.S.

The primary objective of the current study is to assess cancer patient perceived barriers to adherence to oral cancer medications. The results of this survey will aid clinicians in identifying targeted priorities in future programs aimed at improving adherence in patients taking oral cancer medications.

The expected outcome of this proposal is a novel care pathway delivered by pharmacists to improve side effects during oral chemotherapy for patients, a known barrier to adherence, and ultimately to prevent progression and early mortality. Our long-term goal for P3OC is to develop and test new dashboard features to optimize pharmacy care and meet future needs for value-based payment models

We are building an automatic pathology report summarization system. We would like to include human judgement from professionals to help us understand and explain the results, and improve the system. In the evaluation, we will schedule a 30-min meeting do go through the details and for the professional to sign a consent form. The professional will expect to receive twenty documents including ten raw reports and ten summaries of these reports. They will be sent in a random order with no correspondence indicated. For each of the document, you will be asked to answer ten questions. We will evaluate the quality of the summaries based on the time she/he spent on reading the report, answering the questions, and the accuracy of the questions.

We are determining whether upper extremity function improves after surgery for patients presenting with upper extremity lymphedema.

The purpose of the study is to determine how the Cancer Prevention and Control Research Network (CPCRN) researchers and their community partners are operationalizing the nine health equity Principles adopted by the network. The examples, acquired through in-depth interviews, will be used to develop a technical assistance toolkit for CPCRN and the general research community.

We would like to help patients identify what is important to them, i.e., their values, and support communicating that to their caregivers and healthcare providers. We are trying to create a tool that will make it easier to share what is most important to patients with metastatic breast cancer and their caregivers, with the patient's oncology healthcare provider.

Black men are diagnosed with prostate cancer more often than white men, and more commonly die from this disease. Care for advanced prostate cancer has improved a great deal over the past ten years, but these differences have continued. In order to improve equity in cancer care, we want to determine who is not getting the highest quality of care and whether race is associated with differences in care. Our study will ask Black and White men about their experiences with cancer care - if they trusted their doctors, how well their doctors communicated with them, and if they were satisfied with the care they received. We will ask about the challenges they experienced in receiving care, and what might have helped them get better care. We will use these results to design a better way to deliver care.

The purpose of this study is to evaluate the efficacy of sodium thiosulfate (STS) infusion administered during cisplatin-containing chemotherapy cycles in reducing hearing loss in children with newly-diagnosed average-risk medulloblastoma.

The purpose of this study is to test the safety of the two study drugs, venetoclax and selinexor, and to find the highest dose of venetoclax and selinexor that can be given safely when it is combined with chemotherapy drugs (cytarabine or cytarabine and fludarabine). This study tests different doses of venetoclax and selinexor to see which dose is safer in children with leukemia.